Moderna mRNA flu vaccine bests standard shot in peer-reviewed trial, FDA decision due in August
Culture Index
Score Breakdown
Relevance
3/25
Freshness
25/25
Authority
18/20
Brand Signal
6/15
Depth
3/15
5-Axis Cultural Radar
Results published in the New England Journal of Medicine show the mRNA shot reduced flu illness by about 27% more than a standard-dose vaccine
